Our Research

Research Portal

Research Portal profiles world leading research excellence
at the Queen's University of Belfast

  • Fighting bowel cancer with fitness 17 Oct, 2016 Dr Vicky Coyle, from Queen’s Centre for Cancer Research and Cell Biology, has been awarded £750,000 from Stand Up To Cancer, a joint fundraising campaign from Cancer Research UK and Channel 4. Now she is urging people across Northern Ireland to join together with doctors, nurses, scientists and celebrities to back Stand Up To Cancer this October and help accelerate progress into life-saving research into cancer. Cancer and physical activity Dr Coyle will lead the trial in the UK looking into whether taking part in a supervised physical activity programme could help decrease the risk of the disease coming back. The trial is part of a larger international study called the CHALLENGE trial. Developed by the Canadian Cancer Trials Group, the CHALLENGE trial is already underway in Canada, Australia, France, Israel, South Korea and th...)
  • Rosetta space mission ends: Queen’s comet expert reflects on successes 29 Sep, 2016 The European Space Agency’s Rosetta spacecraft will land near a large pit on the surface of comet 67P/Churyumov-Gerasimenko – the same comet onto which it famously delivered the Philae lander in November 2014. Back on Earth, astronomers at Queen’s University Belfast have been supporting the mission by using the world’s largest telescopes to study the comet hundreds of millions of miles away. Members of the solar system team at Queen’s will explain their work at the Science Uncovered event at the Ulster Museum on Friday 30 September. Rosetta’s achievements Professor Alan Fitzsimmons from Queen’s Astrophysics Research Centre will discuss the Rosetta mission on The Sky at Night on BBC4 on Sunday 2 October. He said: “While it will be sad to finally see the end of the mission, Rosetta’s la...)
  • Queen’s University asks 10,000 men ‘how are you doing?’ 27 Sep, 2016 Men across Northern Ireland will receive the survey in the post this week (from Wednesday 28 September). It is part of the ‘Life after Prostate Cancer Diagnosis’ (LAPCD) study – the world’s largest ethically approved study in the world aimed at finding out what life is like for men with prostate cancer. Compare life with and without prostate cancer An important part of this study is to compare men with and without prostate cancer to find out how their experiences differ. To achieve this, Business Services Organisation on behalf of Queen's University Belfast is sending surveys to a random sample of 10,000 men over 50 without prostate cancer to find out about their health and quality of life. The survey includes sensitive questions about symptoms that are common among patients diagnosed and treated for pros...)
  • Predictor of pre-eclampsia discovered by Queen’s University researchers 14 Sep, 2016 The Belfast Researchers discovered that a protein called FABP4 (fatty acid binding protein 4) predicts pre-eclampsia in women with type 1 diabetes, and may be a potential biomarker for pre-eclampsia prediction in pregnant women. What is pre-eclampsia? Pre-eclampsia is a condition in pregnancy characterised by high blood pressure and protein in the urine and can lead to serious complications for the mother. As the only treatment is delivery of the baby, pre-eclampsia can lead to pre-term birth. All women have their blood pressure and urine checked throughout pregnancy and while certain groups who are known to be at risk are monitored closely, to date there is no effective screening programme to predict which women will develop pre-eclampsia. FABP4 protein and pre-eclampsia The study, which was funded by The Wellcome Trust and the Departm...)
  • Queen's University's 'key role' in £10M investment in academic medicine 12 Sep, 2016 The combined funding, approximately £10 million over the next five years, is from Wellcome Trust, participating universities including Queen's, the Public Health Agency’s Research and Development Division (HSC R&D) and Ireland’s Health Research Board. The funding will provide integrated clinical and research training for a total intake of eight postgraduate trainee doctors per year across Ireland, for a five-year period. Applications open in autumn 2016 for intake in July 2017. The programme application, fully supported by HSC R&D and Belfast HSC Trust and the Medical and Dental Training Agency, represents a total investment from HSC R&D Division of up to £1million. Queen's 'key role'  Welcoming the investment, Northern Ireland Health Minister, Michelle O'Niell said: “All-island collaboration o...)
  • Global survey urges people to help explore if dogs are helping save lives of people with epilepsy 05 Sep, 2016 The research is directed at those with epilepsy who are either dog owners or not, and is being undertaken by researchers in the School of Psychology at Queen's, including PhD student Neil Powell from Cobh, Co. Cork, and Professor Peter Hepper. As well as examining whether dogs have the ability to predict epileptic seizures, and if so how they might do this, the survey also focuses on the general physical and psychological impact seizures have on people with epilepsy. This study is set to continue for the next four months and anyone with epilepsy who has not already contributed is invited to participate by clicking on The anonymised questionnaire has been supported by international and national epilepsy charities and organisations across the world, and, to date, people with epilepsy from Australia, S...)
  • Major global study reveals new hypertension and blood pressure genes 12 Sep, 2016 The study was jointly led by Queen Mary University of London (QMUL) and the University of Cambridge. The discoveries include DNA changes in three genes that have much larger effects on blood pressure in the population than previously seen, providing new insights into the physiology of hypertension and suggesting new targets for treatment. High blood pressure or hypertension is a major risk factor for cardiovascular disease and premature death. It is estimated to be responsible for a larger proportion of global disease burden and premature mortality than any other disease risk factor. However, there is limited knowledge on the genetics of blood pressure. The research teams investigated the genotypes of around 347,000 people and their health records to find links between their genetic make-up and cardiovascular health. The participants incl...)
  • Hamilton announces £3.6million investment in research funding 09 Sep, 2016 The Investigators Programme Partnership between Science Foundation Ireland (SFI) and the Department for the Economy (DfE) supports collaborative projects involving universities from Northern Ireland and the Republic of Ireland (RoI) in undertaking internationally peer-reviewed, leading-edge discovery and fundamental research. The five successful projects were selected by SFI Investigators Programme competitive peer review involving international scientists and are in a range of strategically important sectors. Minister Hamilton said: “Following the tremendous success of Northern Ireland universities in SFI’s 2015 Investigators Programme, my Department will be providing almost £3.6million to Queen’s University to support five successful partnership projects. "The projects, which are in key research areas such as Ener...)
  • Superbugs under the microscope as international experts gather at Queen’s 06 Sep, 2016 They will join researchers from Queen’s who are pioneering a new approach in the ‘arms race’ against antibiotic resistant infections. Queen’s scientists are working towards the development of new therapies to boost the body’s own defenses against infection, rather than trying to beat the bugs by attacking them directly with antibiotics. The approach is called ‘host directed therapeutics’ and it focusses on identifying the ‘achilles heel’ within the immune system that allows infection-causing microbes to take hold. It is one of the approaches that will be discussed during the two-day event, hosted by Professor Jose Bengoechea, Director of Centre for Experimental Medicine at Queen’s. Professor Bengoechea’s research into combatting the multidrug-resistant microbe Klebsiella ...)
  • 20,000 people helping to discover new tests and treatments for diabetic kidney disease 02 Jun, 2016 The five-year research project is part of a new £3.7M US-Ireland research partnership which is aiming to explain why some people with diabetes are at higher risk than others of developing kidney failure – vital information that could enable personalised preventative care for those whose genetic profile puts them at risk of developing kidney complications. The grants have been awarded under the US-Ireland Research and Development Partnership Programme. This initiative brings together world-leading experts in diabetes and genetics research at Queen’s University, University College Dublin, University of Helsinki in Finland and the Broad Institute, Boston, USA. Globally, diabetes is a huge public health problem, affecting one in 12 of the world’s population. The rapid upsurge in diabetes is fuelling an increase in the n...)